Replies to post #2477 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

>What are your predictions for Baraclude's ultimate sales numbers?<

I think Baraclude will top out at $500-600M per year. If combination therapy becomes the SoC in HBV, sales ought to reach the high end of this range. JMHO, FWIW